AKT1 and neoplasm: Based on studies on other tumor entities [17,19,48,49] and keratinocytes [50], we proposed that the phosphatidylinositol 3-kinase (PI3K)/AKT pathway could be a key player in the directional migration of HROC383 cells in DCEFs.